Most Read Articles
3 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 3 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Androgen deprivation therapy ups cardiovascular, metabolic risk in Asians

02 Nov 2020

Long-term androgen deprivation therapy (ADT) may exacerbate the risk of cardiovascular and metabolic disorders in Asian patients, a recent study has found.

Thirty-six patients with advanced prostate cancer and had been on ADT for 2 years participated in the study. Metabolic and vascular parameters were assessed every 6 months. The study outcomes were assessed using the Framingham Risk Score (overall cardiovascular risk) and the National Cholesterol Education Program/Adult Treatment Panel guidelines (metabolic risk). A parallel group of 24 prostate cancer not on ADT was also included.

At baseline, most of the participants already had cardiovascular and metabolic problems, the most common of which were hypertension, hyperlipidaemia, and diabetes. Framingham scores at baseline were comparable between arms (p=0.720).

Ten patients in the ADT arm and one non-ADT control died before the end of the study. Major reasons were cancer progression, right cerebellar haemorrhage, and sepsis. Excluding two other ADT patients who dropped out, the final sample included 24 patients in the ADT group and 23 in the control arm.

In this final analytic group, researchers saw that the Framingham score jumped from 41.74±20.94 percent at baseline to 47.24±22.86 percent at 2 years. On the other hand, control patients saw a slight drop, from 39.79±19.86 percent to 37.67±19.93 percent over the same time interval. The temporal change in pulse wave velocity mirrored this trend, too, with a larger increase seen in the ADT arm.

In addition, patients who had been on ADT for 2 years were almost five times as likely to develop metabolic syndrome than controls, though the interaction failed to achieve statistical significance (p=0.068).

Editor's Recommendations
Most Read Articles
3 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 3 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.